載入...
Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
There are a wide range of therapies for metastatic colorectal cancer (CRC) available, but outcomes remain suboptimal. Learning the role of the immune system in cancer development and progression led to advances in the treatment over the last decade. While the field is rapidly evolving, PD-1, and PD-...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527887/ https://ncbi.nlm.nih.gov/pubmed/31139574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00396 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|